Australia’s largest, dedicated Early Phase Clinical Trial experts with extensive experience across simple to complex early phase clinical trials, with the best track record and strong reputation.
Our medical experts work hand-in-glove with sponsors to co-design the optimum study protocol, leveraging our extensive experience to achieve better outcomes for their trials.
Our highly experienced, professional team always goes the extra mile to exceed our clients’ expectations. We take great pride in seeing our satisfied clients return to us for future studies, with repeat clients accounting for more than 80% of our revenue.
Our dedicated 80-bed inpatient clinical trial facility is located within the Alfred Medical Research and Education Precinct, a major tertiary hospital campus with unique access to patient populations and medical expertise.
We are proud of our high independent audit performance history. We have hosted over 100 sponsor audits and achieved multiple positive regulatory inspections from the U.S. Federal Drug Authority (FDA), the European Medicines Agency (EMA) and Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, ANVISA).
Clients can rely on the data from all our clinical study trials being accepted for quality and compliance with the highest regulatory standards, including ICH GCP. Our robust, world class quality system is based on project management and risk management principles with the ultimate goal of ensuring GCP compliance and customer satisfaction.
We have Australia’s largest Early Phase Clinical Trial participant pool, including diverse Caucasian, Japanaese and Chinese populations. Our central Melbourne location provides a large potential candidate recruitment pool, which is accessed through targeted consumer acquisition and retention marketing programs.